Koichi Hayashi - Search Results

Year	Number of Results
2002	9
2003	12
2004	9
2005	14
2006	8
2007	6
2008	9
2009	7
2010	14
2011	10
2012	9
2013	17
2014	14
2015	11
2016	9
2017	2
2018	1
2019	1
2020	5
2021	3
2022	4
2023	9
2024	4

1

Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study.

Endo K, Hayashi K, Hara Y, Miyake A, Takano K, Horikawa T, Yoshino K, Sakai M, Kitamura K, Ito S, Imai N, Fujitani S, Suzuki T. Endo K, et al. Among authors: hayashi k. BMC Nephrol. 2023 Mar 22;24(1):68. doi: 10.1186/s12882-023-03117-1. BMC Nephrol. 2023. PMID: 36949416 Free PMC article.

2

Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients-the role of antidiabetic and antihypertensive medications.

Kitamura K, Hayashi K, Ito S, Hoshina Y, Sakai M, Yoshino K, Endo K, Fujitani S, Suzuki T. Kitamura K, et al. Among authors: hayashi k. Hypertens Res. 2021 May;44(5):508-517. doi: 10.1038/s41440-020-00590-1. Epub 2020 Dec 14. Hypertens Res. 2021. PMID: 33311577 Free PMC article.

3

Renal microcirculation and calcium channel subtypes.

Homma K, Hayashi K, Yamaguchi S, Fujishima S, Hori S, Itoh H. Homma K, et al. Among authors: hayashi k. Curr Hypertens Rev. 2013 Aug;9(3):182-6. doi: 10.2174/1573402110666140131160617. Curr Hypertens Rev. 2013. PMID: 24479750 Free PMC article. Review.

4

Blood pressure regulation and renal microcirculation.

Takenaka T, Hayashi K, Ikenaga H. Takenaka T, et al. Among authors: hayashi k. Contrib Nephrol. 2004;143:46-64. doi: 10.1159/000078711. Contrib Nephrol. 2004. PMID: 15248355 Review. No abstract available.

5

Mechanistic view of renal protective action of calcium channel blockade.

Sugano N, Hayashi K, Hosoya T, Yokoo T. Sugano N, et al. Among authors: hayashi k. Curr Hypertens Rev. 2013 Aug;9(3):187-92. doi: 10.2174/157340210903140415124048. Curr Hypertens Rev. 2013. PMID: 24749517 Review.

6

Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism.

Hasegawa K, Wakino S, Sakamaki Y, Muraoka H, Umino H, Minakuchi H, Yoshifuji A, Naitoh M, Shinozuka K, Futatsugi K, Urai H, Kanda T, Tokuyama H, Hayashi K, Itoh H. Hasegawa K, et al. Among authors: hayashi k. Curr Hypertens Rev. 2016;12(2):95-104. doi: 10.2174/1573402112666160302102217. Curr Hypertens Rev. 2016. PMID: 26931474 Review.

7

Ca2+ channel subtypes and pharmacology in the kidney.

Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Hayashi K, et al. Circ Res. 2007 Feb 16;100(3):342-53. doi: 10.1161/01.RES.0000256155.31133.49. Circ Res. 2007. PMID: 17307972 Review.

8

Involvement of renal sympathetic nerve in pathogenesis of hypertension.

Kumagai H, Onami T, Iigaya K, Takimoto C, Imai M, Matsuura T, Sakata K, Oshima N, Hayashi K, Saruta T. Kumagai H, et al. Among authors: hayashi k. Contrib Nephrol. 2004;143:32-45. doi: 10.1159/000078710. Contrib Nephrol. 2004. PMID: 15248354 Review. No abstract available.

9

T-type Ca channel blockade as a determinant of kidney protection.

Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, Itoh H. Hayashi K, et al. Keio J Med. 2010;59(3):84-95. doi: 10.2302/kjm.59.84. Keio J Med. 2010. PMID: 20881449 Free article. Review.

10

Rho/Rho kinase as a potential target for the treatment of renal disease.

Wakino S, Kanda T, Hayashi K. Wakino S, et al. Among authors: hayashi k. Drug News Perspect. 2005 Dec;18(10):639-43. doi: 10.1358/dnp.2005.18.10.959578. Drug News Perspect. 2005. PMID: 16491166 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

164 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year